Severe viral bronchiolitis and severe acute asthma are common causes of acute respiratory insufficiency in infants and children beyond the neonatal period. Both are associated with considerable morbidity and can be fatal if management is inadequate. However, it is possible to reduce mortality to a minimum with appropriate therapy.
The term 'status asthmaticus' is not used in this review because of uncertainty about precise definition. By 'severe acute asthma' is meant an acute episode of respiratory distress and wheezing not responding to conventional oral and/or inhalational bronchodilator therapy and which if continued unchecked would become lifethreatening.
The approach to management outlined here has been used by the authors for the past 7 years. During each 12 months they see about 30 babies with severe acute bronchiolitis and about 40 children who between them have approximately 60 episodes of severe acute asthma. No patient with uncomplicated severe acute asthma under the authors' care has died in hospital during this period, though an 8-year-old child with very severe asthma who developed a tracheobronchitis caused by influenza A2 virus died in acute respiratory failure. Causes of death in the 4 fatal cases of viral bronchiolitis are outlined in Table I .
Pathophysiology
In both diseases the major pathology is obstruction in the medium and smaller airways. In bronchiolitis this is due to inflammatory oedema and exudate and in asthma to mucosal oedema, mucous plugging, and bronchial muscle spasm. In infants under 12 months of age with asthma, obstruction is due mainly to mucosal oedema and mucus, as *In the 'Personal practice' series of articles authors are invited to give their own views on some current practical problem. bronchial and bronchiolar muscle is poorly developed (Engel, 1962) . As a consequence of widespread airways obstruction, the work of breathing is increased and ventilation-perfusion inequalities develop. Pao2 is invariably below normal if the patient is breathing air. Initially, with severe acute asthma, hyperventilation may produce a low Paco2, but with progress of the disease hypercapnia develops (Simpson, Forfar, and Grubb, 1968) . In acute bronchiolitis it is less common to see hypocapnia even in the initial stages of the illness.
Dehydration from poor fluid intake often associated with vomiting is common, particularly in smaller children. This, combined with hypoxia, poor cardiac output, and increased muscular work, frequently results in metabolic acidosis. the minimum of disturbance. Only essential investigations are undertaken. A chest x-ray is usually taken and arterial blood collected for gas analysis. As all patients have an intravenous infusion, there is no disturbance for feeding, though small amounts of fluid may be given by mouth to help allay restlessness. Sedatives are not used because of the risk of central depression.
Oxygen. As hypoxia is invariably present, oxygen is an important part of therapy and is administered to infants under the age of 18 months in a plastic oxygen cot (Fig. 1) (Orange et al., 1970) , and one of the major effects of corticosteroids is to sensitize the P-adrenergic receptors (McCombs, 1972) . To administer corticosteroids alone, as has been suggested by some writers, is to lose a major part of their pharmacological activity, and adequate control may not be obtained even with massive doses until a fl-adrenergic stimulator is added (Rebuck and Read, 1971) . In infants under 12 months of age, steroids alone are of value because of the small amount of bronchial and bronchiolar muscle. Severe asthma in this age group can be particularly difficult to manage.
f-adrenergic stimulators. Though most children admitted to hospital with acute asthma will have received ,B-adrenergic stimulators without adequate response, these are continued unless dosage has been excessive. They are given by inhalation, using a Bennett twin jet nebulizer driven by a Repco clinical air pump* which has an output of 6 0 1./minute (Fig. 2) . The standard drug has been orciprenaline 2% solution 0-25 ml diluted to 2 ml with isotonic saline or with 10% propylene glycol in isotonic saline for children under the age of 8 years, and orciprenaline 2% 0* 5 ml diluted to 2 ml for children over 8 years. More recently, salbutamol 0*5% respirator solution has been used in similar dosage and appears equally effective. An inhalation usually takes about 10 minutes to administer and is repeated 4-hourly. In the past 6 months the authors have used salbutamol intravenously in a dose of 2 -5 ,ug/kg repeated 3-hourly. This appears a very effective bronchodilator and causes no significant fall in Pao2 (Table II) Aminophylline. Unless aminophylline has been used excessively before admission it is administered intravenously in a dose of 3 to 4 mg/kg given over 10 minutes and repeated 6-hourly. The authors have not seen any side effects from the drug in this dosage provided attention is paid to the correction of dehydration and metabolic acidosis. It is used with caution in any child who has been vomiting.
Corticosteroids. If the patient does not respond rapidly to the ,B-adrenergic stimulator and/or intravenous aminophylline, or is seriously ill at the time of admission, or has received corticosteroids in the previous 6 months, methyl prednisolone 1 mg/kg is given intravenously and repeated every 4 hours. If the patient is very ill or if the maintenance dose of steroids is above 10 mg prednisolone per day, the dose of methyl prednisolone is doubled for the first 12 to 24 hours. Beneficial effects of steroids are seen 4 to 6 hours after the initial dose.
Antibiotics. Antibiotics are not routinely used in patients with acute asthma even when corticosteroids are administered, but are reserved for patients with evidence of associated bacterial infection. As this is uncommon, fewer than 10% of patients receive them. The oral endotracheal tube is then replaced by a polyvinyl chloride nasotracheal tube, since this is more readily fixed and will not kink inside the patient. It is positioned under x-ray control so that its tip lies approximately 1 cm above the carina, and is securely fixed (Stocks, 1970) .
The choice of size of tube is very important. Too large a tube will compress the subglottic mucous membrane and may lead to subglottic oedema or stenosis. Too small a tube will allow an excessive leak of gases from the larynx, and in view of the high inflating pressures required, will make it difficult to achieve adequate alveolar ventilation. Ideally there should be a slight leak of gases from the larynx when the lungs are inflated, but if a tube allows a large leak and the size above is occlusive, the larger tube should be used.
The patient is next attached to a mechanical ventilator. Because of their availability, we prefer the Bennett PR2 or Bird Mark 8, driven by oxygen. However, many types may be used satisfactorily, provided that they are mechanically reliable, have a small apparatus dead space, can deliver tidal volumes within the range of 20 to 100 ml over approximately 1 second with a pressure in the breathing circuit of up to 50 cm H20, and allow for a prolonged expiratory phase. It must be possible to vary the inspired oxygen concentration, and to provide a water vapour content of the inspired gases of at least 40 mg/l. For this latter purpose, we add to the circuit a hot water bath type of vaporizer, the Donnelly Wilson respiratory gas humidifier, and set its temperature so that the gases reach the patient at a temperature of at least 35°C (Stocks, 1973) .
To obtain adequate inspiration through the narrowed airways, a slightly prolonged inspiratory phase of about 1 second is usually necessary, and the driving pressure from the ventilator usually has to be set within the range of 30 to 50 cm H20. A prolonged expiratory phase of 2 to 4 seconds is required, since expiratory flow through the still more narrowed airways depends entirely on intraalveolar pressure. Even with this, expiration is often not completed before it is essential to start the next inspiratory phase. The mean intra-alveolar pressure remains high, which in tum raises the venous pressure, and this may lead to generalized (including cerebral) oedema. For this reason fluid intake is reduced to about 70% of standard requirements.
When an adequate gaseous exchange, as judged on clinical grounds, is being achieved, it should be checked by measuring the Paco2 and Pao2. It is difficult to estimate the required tidal volume by clinical criteria, and commonly the ventilator pressure has to be increased. An inspired oxygen concentration of 50 to 60% will usually achieve a satisfactory Pao2. The concentration is reduced as the patient's condition improves. Paco2 estimations are repeated at least twice daily, and the inspiratory pressure adjusted accordingly.
Complete muscular paralysis during the acute stage is maintained by giving d-tubocurarine 1 mg/kg intravenously whenever movement is seen. It is necessary to have the maximum possible pressure gradient from the endotracheal tube to the alveoli during inspiration, and the presence of any tone within the respiratory musculature will reduce this and rapidly lead to a rise in the Paco2 and fall in the Pao2.
The management of the paralysed patient on a ventilator presents many serious problems. Continuous observation is necessary to ensure that the machine is working and inflating the patient adequately. We have designed an electronic alarm in the circuit which will sense whenever the inspiratory pressure fails to reach a set level and if the expiratory pressure fails to return to zero once in every 10 seconds. Every precaution should be taken to ensure that the endotracheal tube does not come out or become blocked with secretions, but nursing staff must be able to cope should these occur.
In the majority of patients, 2 to 3 days of mechanical ventilation are necessary. When the inspiratory pressure to achieve adequate ventilation falls below 30 cm H20, a trial period off the ventilator is usually indicated. The action of the muscle relaxant is allowed to partially wear off, and is then reversed with atropine (25 ,ug/kg) and neostigmine (50 ,ug/kg Methyl prednisolone is replaced by oral prednisolone and is rapidly reduced over 3 to 4 days. The usual regimen is 30 mg prednisolone in the first 24 hours after the infusion is stopped; 15 mg in the second; and 5 mg or the maintenance steroid dose, should it be larger, in the third; and the normal maintenance dose or the steroids stopped in the fourth 24 hours. Oral theophylline in a dosage appropriate to the child's age together with inhalations of orciprenaline or salbutamol are continued. The majority of patients with severe asthma will be on long-term bronchodilators and after another 2 to 3 days normal maintenance therapy is resumed. Sodium cromoglycate is restarted after the intravenous infusion is stopped.
Discussion
With this approach to management of severe bronchiolitis and severe acute asthma, the authors feel that they have reduced morbidity to a minimum and hopefully eliminated mortality. Death from acute viral bronchiolitis has resulted from unusual medical complications or from inexperience with the use of artificial ventilation when this was first introduced.
The authors have not used bronchial lavage in children with severe asthma and believe that it should not be necessary if facilities for artificial ventilation are adequate. There is now evidence that substantial lung damage occurs during lavage.
Meticulous medical and nursing care is essential in managing severely ill children with acute airways obstruction. This, combined with proper administration of pharmacological agents and the occasional use of artificial ventilation, should insure a satisfactory outcome in virtually all patients. 
